Microbix BiosystemsMBXBF 53 Days Inventory is 504.38 as of Mar. 2026, which is 117% above its 10-year median of 232.55. GuruFocus rates MBXBF with a GF Score™ of 53/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 638 Biotechnology companies, Microbix Biosystems ranks worse than 76.65% on this metric.
The historical rank and industry rank for Microbix Biosystems's Days Inventory or its related term are showing as below:
MBXBF'
s Days Inventory Range Over the Past 10 Years
Min: 210.35 Med: 232.55 Max: 391.73
Current: 391.73
During the past 13 years, Microbix Biosystems's highest Days Inventory was 391.73. The lowest was 210.35. And the median was 232.55.
MBXBF's Days Inventory is ranked worse than 76.65% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs MBXBF: 391.73
Microbix Biosystems's Days Inventory
increased
from Mar. 2025 (325.97) to Mar. 2026 (504.38).
It might indicate that Microbix Biosystems's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Microbix Biosystems's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microbix Biosystems's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.86.
Microbix Biosystems (OTCPK:MBXBF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Microbix Biosystems's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microbix Biosystems's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Microbix Biosystems Days Inventory Related Terms
Microbix Biosystems Days Inventory Historical Data
* Premium members only.
The historical data trend for Microbix Biosystems's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MBXBF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Microbix Biosystems's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbix Biosystems Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Days Inventory distribution charts can be found below:
* The bar in red indicates where Microbix Biosystems's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbix Biosystems (MBXBF) has a Days Inventory of 504.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Microbix Biosystems and its competitors. This is 117% above median its historical median of 232.55. Over the past decade, Microbix Biosystems' Days Inventory has ranged from 210.35 to 391.73. According to the industry distribution chart, Microbix Biosystems ranks #489 out of 638 companies in the Biotechnology industry, placing it in the top 76.6%.
Is Microbix Biosystems' Days Inventory too high?
Microbix Biosystems' current Days Inventory of 504.38 is 117% above median its 10-year median of 232.55. Over the past 10 years, this metric has ranged from a low of 210.35 to a high of 391.73. The Biotechnology industry median Days Inventory is 183.88. Microbix Biosystems' value of 504.38 is 174.3% above this industry median. Based on the distribution chart, Microbix Biosystems ranks #489 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Microbix Biosystems has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Microbix Biosystems ranks #489 out of 638 companies for Days Inventory. This places Microbix Biosystems in the lower half of its industry. The industry median Days Inventory is 183.88. Microbix Biosystems' value of 504.38 is 174.3% above this benchmark. Historically, Microbix Biosystems' own Days Inventory has ranged from 210.35 to 391.73 over the past decade. While the company's 10-year median is 232.55 vs. the industry median of 183.88, Microbix Biosystems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microbix Biosystems's current Days Inventory of 504.38 is 174.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Microbix Biosystems and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbix Biosystems's current Days Inventory is 504.38, which is 117% above median its own 10-year median of 232.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.21 — trading 23.5% above its estimated fair value. The current Days Inventory is 504.38, which is 117% above median its 10-year median of 232.55 and 174.3% above the Biotechnology industry median of 183.88. Microbix Biosystems' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Days Inventory is 504.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microbix Biosystems (MBXBF) Overvalued in 2026?
Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued.
The current stock price of $0.21 is trading 23.5% above its estimated GF Value™ of $0.17.
GuruFocus considers Microbix Biosystems to be Modestly Overvalued.
Key valuation signals for MBXBF:
Days Inventory: 504.38 (117% above median its 10-year median of 232.55)
GF Value™: $0.17 vs. price of $0.21 (23.5% above fair value)
Industry Position: 174.3% above the Biotechnology median (#489 of 638)
No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
53GF Score
Get the complete analysis for MBXBF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBXBF has been successfully added to your 
